Skip to content

Clinical trials

Parkinsonian Disorders trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Country / region: Spain Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20122
20131
20144
20193
20202
20212
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting1
Enrolling by invitation1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Adamas Pharmaceuticals, Inc.4
Novartis Pharmaceuticals3
Bial R&D Investments, S.A.2
Theravance Biopharma2
Fundacion Clinic per a la Recerca Biomédica1
Greece 2021 Committee1
Institute for Neurodegenerative Disorders1
University of Castilla-La Mancha1
University of Oviedo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinsonian Disorders20
Parkinson Disease19
Movement Disorders9
Dyskinesias7
Central Nervous System Diseases6
Neurodegenerative Diseases6
Brain Diseases4
Nervous System Diseases4
Cognitive Dysfunction2
Dizziness2

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.